Clinical Trial Update: Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT) [Phase 4]

View source ↗

Summary

Phase 4 trial updating pharmacokinetics of anidulafungin given as a single IV dose in obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity

Drugs mentioned

• Anidulafungin (anidulafungin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Obesity Morbid | Phase 4 | Status: COMPLETED